Zhao Yin-nong

509 total citations
24 papers, 406 citations indexed

About

Zhao Yin-nong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zhao Yin-nong has authored 24 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Zhao Yin-nong's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer Mechanisms and Therapy (3 papers). Zhao Yin-nong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer Mechanisms and Therapy (3 papers). Zhao Yin-nong collaborates with scholars based in China, Singapore and United States. Zhao Yin-nong's co-authors include Jihong Zhao, Shan Huang, Shan Huang, Guobin Wu, Jiye Zhu, Lei Zhao, Chao‐Yuan Huang, Fang Lian, Jiazhou Ye and Min Wang and has published in prestigious journals such as PLoS ONE, Cancer Letters and Digestive Diseases and Sciences.

In The Last Decade

Zhao Yin-nong

23 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhao Yin-nong China 10 156 114 112 99 85 24 406
Jun Qian China 14 110 0.7× 185 1.6× 79 0.7× 90 0.9× 125 1.5× 39 508
Hiroyuki Nojima Japan 13 362 2.3× 138 1.2× 195 1.7× 144 1.5× 129 1.5× 41 647
Nanya Wang China 13 150 1.0× 148 1.3× 71 0.6× 37 0.4× 86 1.0× 29 450
Miral S. Grandhi United States 8 198 1.3× 144 1.3× 173 1.5× 117 1.2× 163 1.9× 39 544
Eleonora Liguori Italy 9 232 1.5× 174 1.5× 92 0.8× 58 0.6× 64 0.8× 11 476
Marie Pierre Chenard France 9 90 0.6× 52 0.5× 82 0.7× 81 0.8× 44 0.5× 17 337
Milica Stefanović Spain 9 146 0.9× 78 0.7× 25 0.2× 104 1.1× 96 1.1× 26 454
Thomas Ying Canada 8 97 0.6× 75 0.7× 116 1.0× 62 0.6× 39 0.5× 12 399
Marlena Messer Germany 9 275 1.8× 187 1.6× 81 0.7× 75 0.8× 61 0.7× 13 535

Countries citing papers authored by Zhao Yin-nong

Since Specialization
Citations

This map shows the geographic impact of Zhao Yin-nong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Yin-nong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Yin-nong more than expected).

Fields of papers citing papers by Zhao Yin-nong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao Yin-nong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Yin-nong. The network helps show where Zhao Yin-nong may publish in the future.

Co-authorship network of co-authors of Zhao Yin-nong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Yin-nong. A scholar is included among the top collaborators of Zhao Yin-nong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Yin-nong. Zhao Yin-nong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Jianwen, et al.. (2021). A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. World Neurosurgery. 159. e285–e302. 3 indexed citations
3.
Liang, Sha, Fang Lian, Kezhi Li, et al.. (2018). Under-expression of LKB1 is associated with enhanced p38-MAPK signaling in human hepatocellular carcinoma.. PubMed. 11(11). 5525–5535. 5 indexed citations
4.
Chen, Zhigang, Jiye Zhu, Chao‐Yuan Huang, et al.. (2015). The Association between Three Cyclooxygenase-2 Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis. PLoS ONE. 10(3). e0118251–e0118251. 8 indexed citations
5.
Zhu, Jiye, Shan Huang, Guobin Wu, et al.. (2015). Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 60(10). 3019–3031. 26 indexed citations
6.
Huang, Chao‐Yuan, Xinping Huang, Jiye Zhu, et al.. (2015). miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncology Reports. 33(6). 2889–2898. 73 indexed citations
7.
Wu, Guobin, Chao‐Yuan Huang, Shan Huang, et al.. (2014). Primary hepatic non-Hodgkin’s lymphoma with rectal cancer: A case report. Oncology Letters. 9(1). 324–326. 2 indexed citations
8.
Ma, Liang, et al.. (2013). Impact of treatment strategies on patients with hepatocellular carcinoma of less than 10 cm but with portal vein tumor thrombus. Zhonghua gan-dan waike zazhi. 19(3). 165–170. 2 indexed citations
9.
Huang, Shengxin, Feixiang Wu, Min Luo, et al.. (2013). The Glutathione S-Transferase P1 341C>T Polymorphism and Cancer Risk: A Meta-Analysis of 28 Case-Control Studies. PLoS ONE. 8(2). e56722–e56722. 17 indexed citations
10.
Ye, Jiazhou, Feixiang Wu, Zhao Yin-nong, Le‐Qun Li, & Xue‐Mei You. (2012). Recurrence after anatomic versus nonanatomic resection for hepatocellular carcinoma: a Meta-analysis. Zhonghua gan-dan waike zazhi. 18(8). 582–588.
11.
Zhong, Jian‐Hong, et al.. (2011). Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems. Scandinavian Journal of Gastroenterology. 46(6). 645–651. 7 indexed citations
12.
Yin-nong, Zhao. (2009). Expression and clinical significance of Rhoc and Survivin mRNA in hepatocellular carcinoma. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations
13.
Wu, Feixiang, Qi Wang, Zhiming Zhang, et al.. (2009). Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy. Cancer Letters. 279(2). 163–170. 25 indexed citations
14.
Tan, Shengkui, Xiaoqiang Qiu, Hongping Yu, et al.. (2008). [Evaluation of the risk of clonorchiasis inducing primary hepatocellular carcinoma].. PubMed. 16(2). 114–6. 13 indexed citations
15.
Zhao, Jihong, et al.. (2004). Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. International Journal of Oral and Maxillofacial Surgery. 33(5). 463–466. 63 indexed citations
16.
Liang, Anmin, et al.. (2004). [Comprehensive therapy for primary liver cancer: a report of 607 cases].. PubMed. 23(2). 211–4. 2 indexed citations
17.
Zhang, Nan, et al.. (2004). The roles of centrosome in cancer development. Drug News & Perspectives. 17(3). 195–195. 3 indexed citations
18.
Yang, Er-Bin, LiuLiang Qin, Zhao Yin-nong, Kai Zhang, & Pierce K. H. Chow. (2003). Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma. International Journal of Molecular Medicine. 11(6). 773–8. 3 indexed citations
19.
Mo, Qinguo, et al.. (2003). [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].. PubMed. 22(2). 189–91. 5 indexed citations
20.
Yang, Er-Bin, et al.. (2001). Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: Associated with the elevation of serum α-fetoprotein. International Journal of Oncology. 19(3). 513–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Qian Breakdown of academic impact, for papers by Hiroyuki Nojima Breakdown of academic impact, for papers by Nanya Wang Breakdown of academic impact, for papers by Miral S. Grandhi Breakdown of academic impact, for papers by Eleonora Liguori Breakdown of academic impact, for papers by Marie Pierre Chenard Breakdown of academic impact, for papers by Milica Stefanović Breakdown of academic impact, for papers by Thomas Ying Breakdown of academic impact, for papers by Marlena Messer
Rankless by CCL
2026